BRCA2 and neoplasm: Similarly, having survived the crisis of BRCA2 loss by p53 mutation and/or other means, tumor cells may be able to bypass the requirement for HR, such that restoration of fork protection is then sufficient to deal with replication stress from agents like olaparib and cisplatin, as recently observed9.